EBQ:Validation and refinement of scores to predict very early stroke risk after transient ischaemic attack: Difference between revisions

No edit summary
(Completed all empty sections)
 
(4 intermediate revisions by 3 users not shown)
Line 1: Line 1:
PMID 17258668
{{JC info
{{JC info
| title= Validation and refinement of scores to predict very early stroke risk after transient ischaemic attack
| title= Validation and refinement of scores to predict very early stroke risk after transient ischaemic attack
Line 14: Line 13:
| fulltexturl= http://www.thelancet.com/journals/lancet/article/PIIS0140-6736(07)60150-0/fulltext
| fulltexturl= http://www.thelancet.com/journals/lancet/article/PIIS0140-6736(07)60150-0/fulltext
| pdfurl= http://emjournalclub.com/uploads/ABCD2_Lancet.pdf
| pdfurl= http://emjournalclub.com/uploads/ABCD2_Lancet.pdf
| status = Complete
}}
}}


==Clinical Question==
==Clinical Question==
Aims: To validate two prognostic scores for early risk of stroke after TIA and to derive and validate a unified score optimized for prediction of 2-day stroke risk to inform emergency management


==Conclusion==
==Conclusion==
*The ABCD2 score (combining elements of the ABCD and California scores) predicts stroke risk within 2, 7, and 90 days after TIA
*Higher ABCD2 scores correlate with increased short-term stroke risk
*Scores >=4 identify patients at highest risk who warrant urgent evaluation and admission


==Major Points==  
==Major Points==
*The ABCD2 score unified two existing prediction tools (ABCD and California) into a single validated instrument
*Score components: Age >=60 (1pt), BP >=140/90 (1pt), Clinical features - unilateral weakness (2pt) or speech impairment without weakness (1pt), Duration >=60min (2pt) or 10-59min (1pt), Diabetes (1pt)
*2-day stroke risk by score: 0-3 (low) 1.0%, 4-5 (moderate) 4.1%, 6-7 (high) 8.1%
*The score performs better than either predecessor alone for stroke risk stratification
*Widely adopted in emergency medicine for TIA risk stratification and disposition decisions


==Study Design==
==Study Design==
*Retrospective validation study using pooled data from existing cohorts
*Derivation cohort: 1,916 TIA patients from Oxfordshire, UK
*Validation cohorts: 2,893 patients from California and 1,891 from additional UK sites
*Primary Outcome: stroke within 2, 7, and 90 days of TIA
 
==Population==
==Population==
===Inclusion Criteria===
*Patients diagnosed with TIA by treating physician or neurologist
*Sufficient clinical data to calculate ABCD2 score
===Exclusion Criteria===
*Patients with stroke rather than TIA at presentation
*Insufficient follow-up data
===Patient Demographics===
===Patient Demographics===
===Inclusion Criteria===
===Inclusion Criteria===
Line 33: Line 51:
===Exclusion Criteria===
===Exclusion Criteria===


==Interventions==  
==Interventions==
*No therapeutic intervention; this was a predictive score derivation and validation study
*ABCD2 score calculated retrospectively from recorded clinical data
*Stroke outcomes ascertained through chart review and follow-up
 
==Outcomes==
==Outcomes==
===Primary Outcome===
*Stroke within 2 days by ABCD2 score:
**Score 0-3: 1.0%
**Score 4-5: 4.1%
**Score 6-7: 8.1%
===Secondary Outcomes===
*7-day stroke risk: 1.2% (low), 5.9% (moderate), 11.7% (high)
*90-day stroke risk: 3.1% (low), 9.8% (moderate), 17.8% (high)
*C-statistic for 7-day risk: 0.72 (validation cohort)


===Primary Outcome===
===Primary Outcome===
Line 54: Line 83:


==Funding==
==Funding==
*UK Medical Research Council
*Wellcome Trust


==Sources==
==Sources==
Line 60: Line 90:


[[Category:EBQ]]
[[Category:EBQ]]
[[Category:Neuro]]
[[Category:Neurology]]

Latest revision as of 22:52, 21 March 2026

Complete Journal Club Article
Johnston S. et al.. "Validation and refinement of scores to predict very early stroke risk after transient ischaemic attack". Lancet. 2007. 369:(9558):283-9.
PubMed Full text PDF

Clinical Question

Aims: To validate two prognostic scores for early risk of stroke after TIA and to derive and validate a unified score optimized for prediction of 2-day stroke risk to inform emergency management

Conclusion

  • The ABCD2 score (combining elements of the ABCD and California scores) predicts stroke risk within 2, 7, and 90 days after TIA
  • Higher ABCD2 scores correlate with increased short-term stroke risk
  • Scores >=4 identify patients at highest risk who warrant urgent evaluation and admission

Major Points

  • The ABCD2 score unified two existing prediction tools (ABCD and California) into a single validated instrument
  • Score components: Age >=60 (1pt), BP >=140/90 (1pt), Clinical features - unilateral weakness (2pt) or speech impairment without weakness (1pt), Duration >=60min (2pt) or 10-59min (1pt), Diabetes (1pt)
  • 2-day stroke risk by score: 0-3 (low) 1.0%, 4-5 (moderate) 4.1%, 6-7 (high) 8.1%
  • The score performs better than either predecessor alone for stroke risk stratification
  • Widely adopted in emergency medicine for TIA risk stratification and disposition decisions

Study Design

  • Retrospective validation study using pooled data from existing cohorts
  • Derivation cohort: 1,916 TIA patients from Oxfordshire, UK
  • Validation cohorts: 2,893 patients from California and 1,891 from additional UK sites
  • Primary Outcome: stroke within 2, 7, and 90 days of TIA

Population

Inclusion Criteria

  • Patients diagnosed with TIA by treating physician or neurologist
  • Sufficient clinical data to calculate ABCD2 score

Exclusion Criteria

  • Patients with stroke rather than TIA at presentation
  • Insufficient follow-up data

Patient Demographics

Inclusion Criteria

Exclusion Criteria

Interventions

  • No therapeutic intervention; this was a predictive score derivation and validation study
  • ABCD2 score calculated retrospectively from recorded clinical data
  • Stroke outcomes ascertained through chart review and follow-up

Outcomes

Primary Outcome

  • Stroke within 2 days by ABCD2 score:
    • Score 0-3: 1.0%
    • Score 4-5: 4.1%
    • Score 6-7: 8.1%

Secondary Outcomes

  • 7-day stroke risk: 1.2% (low), 5.9% (moderate), 11.7% (high)
  • 90-day stroke risk: 3.1% (low), 9.8% (moderate), 17.8% (high)
  • C-statistic for 7-day risk: 0.72 (validation cohort)

Primary Outcome

Secondary Outcomes

Subgroup analysis

Criticisms & Further Discussion

Funding

  • UK Medical Research Council
  • Wellcome Trust

Sources